Javed Sultan Professor Michael Griffin Emeritus Professor John Kirby Dr Brian Shenton Emeritus Professor Chris Seal et al. | Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery | 2012 |
|
Mohamed Noormohamed Susan Stamp Dr Brian Shenton Dr Patrick Kesteven Dr Noel Carter et al. | Effects of extra corporeal membrane oxygenation (ECMO) on liver function and histology, in a porcine model of uncontrolled non heart beating donor (NHBD) | 2010 |
|
Mohamed Noormohamed Susan Stamp Dr Noel Carter Dr Brian Shenton Dr Kathryn White et al. | Porcine model of extra-corporeal membrane oxygenation (ECMO) in the uncontrolled non-heart beating donor; Assessing tissue injury [meeting abstract] | 2010 |
|
Mohamed Noormohamed Susan Stamp Dr Noel Carter Dr Brian Shenton Steven White et al. | Porcine model of extra-corporeal membrane oxygenation (ECMO) in the uncontrolled non-heart beating donor; The effect on renal viability [meeting abstract] | 2010 |
|
Mohamed Noormohamed Susan Stamp Dr Brian Shenton Steven White David Talbot et al. | A Simplified Circuit Design for Oxygenated Sanguinous Perfusion of the Non-Heart Beating Donor Liver, Kidney and Pancreas | 2009 |
|
Susan Stamp Mohamed Noormohamed Dr Brian Shenton David Talbot
| An Audit of Sudden Deaths in Accident and Emergency Unit as an On-Going Review of Potential NHBD Donors | 2009 |
|
Dr Ali Aldibbiat Susan Stamp Dr Brian Shenton Professor James Shaw Dr Noel Carter et al. | Improved Preservation of Non Heart-Beating- Donor Pancreases Prior to Islet Isolation Using Portal Venous Oxygen Persufflation. | 2009 |
|
Professor Colin Wilson Susan Stamp Dr Brian Shenton David Talbot
| Is a low K+ organ preservation solution better for vascular endothelium? | 2009 |
|
Susan Stamp Mohamed Noormohamed Dr Brian Shenton David Talbot
| Poor Perfusion of Retrieved Kidneys from Non-Heart Beating Donors: The Impact of Machine Perfusion | 2009 |
|
Mohamed Noormohamed Susan Stamp Dr Brian Shenton David Talbot
| Porcine Model of Extra-Corporeal Membrane Oxygenation (ECMO) in the Uncontrolled Non-Heart Beating Donor (NHDB); the Effect on Liver Viability | 2009 |
|
Mohamed Noormohamed Susan Stamp Dr Brian Shenton David Talbot
| Porcine Model of Extra-Corporeal Membrane Oxygenation (ECMO) in the Uncontrolled Non-Heart Beating Donor; the Effect on Renal Viability | 2009 |
|
Dr Ali Aldibbiat Susan Stamp Dr Brian Shenton Professor James Shaw David Talbot et al. | Portal venous oxygen persufflation for the preservation of non heart-beating-donor pancreases prior to islet isolation | 2009 |
|
Professor Rakesh Heer Professor Craig Robson Dr Brian Shenton Professor Hing Leung
| The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population (vol 2, pg 572, 2007) | 2008 |
|
Dhakshina Vijayanand Professor Colin Wilson Dr Brian Shenton Susan Stamp Dr Katrina Wood et al. | A comparison of C4d staining in renal allograft biopsies from heart beating and non heart beating donors | 2007 |
|
Dr Ali Aldibbiat Dr Brian Shenton Professor James Shaw Dr Noel Carter Professor Derek Manas et al. | Hypothermic machine perfusion for preservation and viability assessment of porcine non-heart-beating-donor pancreas: Initial results | 2007 |
|
Dr Brian Shenton William Cunliffe Professor Thomas Lennard
| Stat3 expression is a poor prognostic marker for invasive breast cancer | 2007 |
|
Professor Rakesh Heer Professor Craig Robson Dr Brian Shenton Professor Hing Leung
| The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population | 2007 |
|
Dr Karthik MaruthaChalam Dr Gendie Lash Dr Brian Shenton Alan Horgan
| Tumour cell dissemination following endoscopic stent insertion | 2007 |
|
Dr Latika Sibal Dr Ali Aldibbiat Ian Harvey Dr Brian Shenton Dr Graham Holliman et al. | [abstract] Identification and quantification of circulating endothelial progenitor cells in individuals with Type 1 diabetes and non-diabetic controls | 2006 |
|
Muhammed Gok Dr Brian Shenton Dr David Mantle David Rix Bryon Jaques et al. | Ischemia-reperfusion injury in cadaveric nonheart beating, cadaveric heart beating and live donor renal transplants | 2006 |
|
Professor Rakesh Heer Dr Anne Collins Professor Craig Robson Dr Brian Shenton Professor Hing Leung et al. | KGF suppresses α2β1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epithelium | 2006 |
|
Sophie Noblett Dr Christopher Snowden Dr Brian Shenton Alan Horgan
| Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection | 2006 |
|
Adam Davison Dr Brian Shenton
| The effects of neoadjuvant tamoxifen therapy on the expression of ER, AR, EGFR growth factors and the tetraspanin protein CD9 | 2006 |
|
John Asher Professor Colin Wilson Muhammed Gok Dr Brian Shenton David Rix et al. | A simple cardiovascular risk score can predict poor outcome in NHBD renal transplantation | 2005 |
|
Dr Bijayeswar Vaidya Dr Brian Shenton Susan Stamp Dr Alison Dickinson Dr Petros Perros et al. | Analysis of peripheral blood T-cell subsets in active thyroid-associated ophthalmopathy: Absence of effect of octreotide-LAR on T-cell subsets in patients with thyroid-associated ophthalmopathy | 2005 |
|
John Asher Dr Brian Shenton Susan Stamp Muhammed Gok David Talbot et al. | Anti-vimentin antibody detection in recipients of heart-beating and non-heart beating donor kidneys | 2005 |
|
Caroline Hodgson Adam Davison Dr Brian Shenton
| Can 3 weeks of neoadjuvant tamoxifen therapy improve survival in breast cancer? | 2005 |
|
Dr Anna Wroe Dr Brian Shenton David Talbot
| Cardiovascular risk assessment scoring system for the determination of cardiovascular mortality in renal transplant patients | 2005 |
|
Muhammed Gok John Asher Dr Brian Shenton Professor Naeem Soomro Bryon Jaques et al. | Do recipients of kidneys from donors treated with streptokinase develop anti-streptokinase antibodies? | 2005 |
|
Dr Jonathan Coxhead Wendy Bal Dr Brian Shenton Dr Liz Williams Professor John Mathers et al. | Effect of butyrate on induction of aneuploidy in colorectal carcinoma cell lines | 2005 |
|
Ajay Gupta Dr Brian Shenton Susan Stamp Bryon Jaques Professor Derek Manas et al. | Functional assessment of Epstein Barr virus specific cytotoxic T cells using MHC class I-PEPTIDE complexes | 2005 |
|
Muhammed Gok John Asher Ajay Gupta Dr Brian Shenton Dr Helen Robertson et al. | The effect of inadequate in situ perfusion in the non heart-beating donor | 2005 |
|
Dr Jonathan Smout Dr Brian Shenton Professor Gerard Stansby
| Treadmill exercise in claudicants on aspirin results in improved antioxidant status but only minimal platelet activation | 2005 |
|
John Asher Professor Colin Wilson Muhammed Gok Dr Brian Shenton David Rix et al. | Viability assessment allows use of uncontrolled and extended criteria kidneys from donors after cardiac death. | 2005 |
|
Dr Brian Shenton Bryon Jaques David Talbot Dr Arun Gupta Dr Caroline Matthews et al. | Vimentin antibodies: A non-HLA antibody as a potential risk factor in renal transplantation | 2005 |
|
Dr Brian Shenton
| Vimentin antibodies: A potential role in early graft damage and late graft failure in renal allografts? | 2005 |
|
Dr Jonathan Smout Dr Brian Shenton Professor Gerard Stansby
| Combination Antiplatelet Therapy in Patients with Peripheral Vascular Bypass Grafts | 2004 |
|
John Asher Professor Colin Wilson Muhammed Gok Dr Brian Shenton Basav Sen et al. | Does donor cardiopulmonary resuscitation time affect outcome in uncontrolled non-heart-beating donor renal transplants? | 2004 |
|
Edward Leung Dr Brian Shenton Professor Graham Jackson Professor Kate Gould David Talbot et al. | Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler | 2004 |
|
John Asher Professor Colin Wilson Muhammed Gok Professor Naeem Soomro David Rix et al. | Factors predicting duration of delayed graft function in non-heart-beating donor kidney transplantation | 2004 |
|
Muhammed Gok John Asher Dr Brian Shenton David Rix Professor Naeem Soomro et al. | Graft function after kidney transplantation from non-heartbeating donors according to Maastricht category | 2004 |
|
Dr Ahmed Chishti Dr Brian Shenton Emeritus Professor John Kirby Dr Simon Baudouin
| Neutrophil chemotaxis and receptor expression in clinical septic shock | 2004 |
|
Ajay Gupta Dr Brian Shenton Muhammed Gok John Asher Dr Bridget Wilkins et al. | Plasma cell myeloma variant of post-transplant lymphoproliferative disorder in a solid organ transplant recipient: a case report | 2004 |
|
Muhammed Gok Ajay Gupta Dr Brian Shenton Dr Helen Robertson Professor Naeem Soomro et al. | Renal transplants from non-heart beating paracetamol overdose donors | 2004 |
|
Dr Jonathan Smout Dr Brian Shenton Susan Stamp Professor Gerard Stansby
| The effect of EDTA-FACSflow fluid on platelet activation markers | 2004 |
|
Seb Aspinall Susan Stamp Andrew Davison Dr Brian Shenton Professor Thomas Lennard et al. | The proliferative effects of 5-androstene-3β,17β-diol and 5α-dihydrotestosterone on cell cycle analysis and cell proliferation in MCF7, T47D and MDAMB231 breast cancer cell lines | 2004 |
|
Eileen Leung Dr Brian Shenton Katherine Green Katherine Gould Professor Graham Jackson et al. | Changes in EBV gene load in renal transplant recipients | 2003 |
|
Dr Jonathan Smout Dr Brian Shenton Professor Gerard Stansby
| Combination antiplatelet therapy in patients with peripheral vascular bypass grafts: a randomized controlled trial | 2003 |
|
Muhammed Gok Dr Brian Shenton David Talbot
| Comparison of perfusate activities of glutathione S-transferase, alanine aminopeptidase and fatty acid binding protein in the assessment of non-heart-beating donor kidneys | 2003 |
|
Muhammed Gok Dr Brian Shenton Dr David Mantle Bryon Jaques Professor Naeem Soomro et al. | Creatinine clearance and viability biomarkers of machine perfused non-heart-beating donors: Is there a correlation? | 2003 |
|
Seb Aspinall Susan Stamp Adam Davison Dr Brian Shenton Professor Thomas Lennard et al. | Dehydroepiandrosterone sulphate serum levels in women with breast cancer and growth actions of its metabolites 5alphadihydrotestosterone and 5-androstene-3beta,17beta-diol on MCF7, T47D, and MDAMB231 breast cancer cell lines | 2003 |
|
Muhammed Gok Dr Brian Shenton Dr David Mantle Professor Naeem Soomro Bryon Jaques et al. | Do tissue damage biomarkers used to assess machine-perfused NHBD kidneys predict long-term renal function post-transplant? | 2003 |
|
David Talbot Dr Brian Shenton Muhammed Gok
| Experiences learned in the successful establishment of a nonheart beating donor program for renal transplantation | 2003 |
|
Muhammed Gok Dr Brian Shenton Professor Naeem Soomro Bryon Jaques Professor Derek Manas et al. | How to improve the quality of kidneys from non-heart-beating donors: A randomised controlled trial of thrombolysis in non-heart-beating donors | 2003 |
|
Seb Aspinall Dr David Cook Dr Brian Shenton Andrew Griffiths Clive Griffith et al. | Serum adrenal androgens in women in primary operable breast cancer and their relationship with age and body mass index | 2003 |
|
Muhammed Gok Dr Brian Shenton Dr David Mantle Professor Naeem Soomro Bryon Jaques et al. | Use of thrombolytic streptokinase as a preflush in the NHBD procurement | 2003 |
|
Muhammed Gok Dr Brian Shenton David Talbot
| Use of two biomarkers of renal ischemia to assess machine-perfused non-heart-beating donor kidneys | 2003 |
|
David Talbot Professor Derek Manas Dr Brian Shenton
| [Meeting abstract] Comparison of panel reactive antibody methodologies | 2002 |
|
Seb Aspinall Susan Stamp Dr Ian Brotherick Dr Brian Shenton Andrew Griffiths et al. | A method of tumour androgen receptor expression in primary operable breast cancer measured by flow cytometry | 2002 |
|
Chris Wigfield Dr Huw Golledge Dr Brian Shenton Emeritus Professor John Kirby Professor John Dark et al. | Ameliorated reperfusion injury in lung transplantation after reduction of brain death induced inflammatory graft damage in the donor | 2002 |
|
Fiona Girdler Dr Ian Brotherick Professor Thomas Lennard Dr James Young Dr Brian Shenton et al. | Changes in the expression of oestrogen receptors (ER alpha and ER beta) in the MCF7 cell line with endocrine treatments | 2002 |
|
Muhammed Gok Dr Brian Shenton Dr Marie Mathers Dr Helen Robertson David Talbot et al. | Comparison of glutathione S-transferase and alanyl aminopeptidase as viability markers in a porcine NHBD model | 2002 |
|
Fiona Girdler Dr Ian Brotherick William Cunliffe Professor Thomas Lennard Dr Brian Shenton et al. | ER alpha and ER alpha exon5 expression in tamoxifen treated tumours | 2002 |
|
Muhammed Gok Dr Brian Shenton Dr Helen Robertson Dr Marie Mathers Dr Doug Aitchison et al. | Improving the quality of kidneys from non-heartbeating donors, using streptokinase: An animal model | 2002 |
|
Muhammed Gok Dr Brian Shenton Professor Naeem Soomro Professor Derek Manas David Talbot et al. | Long-term renal function after transplantation from non-heart-beating donor kidneys | 2002 |
|
Muhammed Gok Dr Brian Shenton Dr Helen Robertson Professor Naeem Soomro Bryon Jaques et al. | Long-term renal function in kidneys from non-heart-beating donors: A single-center experience | 2002 |
|
Dr Ian Brotherick Susan Stamp William Cunliffe Dr Gail Higginbottom Dr James Young et al. | Neoadjuvant tamoxifen treatment and its effect on MUC1 expression in primary breast cancer | 2002 |
|
Seb Aspinall Dr Ian Brotherick Dr David Cook Dr Brian Shenton Andrew Griffiths et al. | Serum testosterone in women with primary operable breast cancer | 2002 |
|
Dr Ian Brotherick Susan Stamp Fiona Girdler William Cunliffe Professor Thomas Lennard et al. | The influence of tamoxifen treatment on E-cadherin expression in primary breast cancer | 2002 |
|
Susan Stamp Seb Aspinall Dr Ian Brotherick Dr Brian Shenton Professor Thomas Lennard et al. | The use of multiparameter flow cytometry to quantify the androgen receptor in primary breast cancer | 2002 |
|
Fiona Girdler Dr Ian Brotherick William Cunliffe Professor Thomas Lennard Dr James Young et al. | Three weeks of tamoxifen treatment alters the expression of ER alpha, ER beta and pS2 | 2002 |
|
Eileen Leung Dr Brian Shenton Professor Graham Jackson Professor Kate Gould David Talbot et al. | Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood | 2002 |
|
Muhammed Gok Dr Brian Shenton Dr David Mantle Professor John Dark David Talbot et al. | Use of streptokinase in a non-heart-beating donor animal model | 2002 |
|
Fiona Girdler Dr Ian Brotherick Dr Brian Shenton
| ARMS (TM) allele-specific amplification-based detection of mutant p53 DNA and mRNA in tumors of the breast | 2001 |
|
Fiona Girdler Dr Ian Brotherick Professor Thomas Lennard Dr James Young Dr Brian Shenton et al. | Changes in the expression of oestrogen receptors (ER alpha and ER beta) in the MCF7 cell line with endocrine treatments. | 2001 |
|
Dr Helen Robertson Alison Bell Dr Brian Shenton David Talbot
| CMV infection as a contributory factor for renal allograft injury and loss | 2001 |
|
Muhammed Gok Dr Brian Shenton Professor Derek Manas Professor Naeem Soomro David Talbot et al. | Creatinine clearance in recipients of kidneys from non-heartbeating donors | 2001 |
|
Susan Stamp Seb Aspinall Dr Brian Shenton Professor Thomas Lennard
| Detection of the androgen receptor in primary human breast cancer by multiparameter flow cytometry technique | 2001 |
|
Adillah Binti Yusof Dr Ian Brotherick William Cunliffe Professor Thomas Lennard Dr James Young et al. | ER alpha and ER alpha Delta 5 expression in tamoxifen-treated breast tumours. | 2001 |
|
Dr Ahmed Chishti Professor John Dark Dr Patrick Kesteven Dr Hazel Powell Dr Christopher Snowden et al. | Expression of chemokine receptors CXCR1 and CXCR2 during cardiopulmonary bypass | 2001 |
|
Dr Brian Shenton Professor Derek Manas Professor John Dark David Talbot Alison Bell et al. | Immune monitoring of anti-thymocyte globulin (ATG) treatment in transplant patients | 2001 |
|
Dr Jonathan Hanson Jagnohan Varma Professor Adrian Allen Dr Brian Shenton Dr James Young et al. | MUC1 expression in primary breast cancer: The effect of tamoxifen treatment | 2001 |
|
Muhammed Gok Dr Brian Shenton David Talbot
| Pump upgrade for machine perfusion at the Freeman Hospital in Newcastle | 2001 |
|
Ian Bradford Alison Bell Dr Brian Shenton Jagnohan Varma Dr Stefan Plusa et al. | Regulation of chemotaxis by alpha chemokines and their receptors is abnormal in ulcerative colitis | 2001 |
|
Seb Aspinall Susan Stamp Dr Brian Shenton Dr David Cook Clive Griffith et al. | The relationship between serum androstenedione, dehydroepiandrosterone-sulphate, testosterone, and tumour androgen receptor expression in women with primary breast cancer. | 2001 |
|
Dr Ian Brotherick Fiona Girdler Dr Brian Shenton
| The variation in expression of cytokeratin phenotypes in primary breast cancer | 2001 |
|
Fiona Girdler Dr Ian Brotherick William Cunliffe Professor Thomas Lennard Dr James Young et al. | Three weeks of tamoxifen treatment alters the expression of ER alpha, ER beta and pS2. | 2001 |
|
Fiona Girdler Dr Brian Shenton Dr James Young Dr Ian Brotherick
| Use of the monoclonal antibody DAKO-ERβ (8D5-1) to measure oestrogen receptor beta in breast cancer cells | 2001 |
|
Muhammed Gok Dr Brian Shenton Dr Doug Aitchison Professor John Dark David Talbot et al. | Viability assessment of non-heart beating donor kidneys: Alanine-aminopeptidase and glutathione s-transferase: An animal model | 2001 |
|
Dr Brian Shenton
| Clinical value of monitoring efficacy of ATG therapy in transplant patients | 2000 |
|
Dr David Mantle Dr Brian Shenton Muhammed Gok Professor Naeem Soomro Professor Derek Manas et al. | Machine perfusion and viability assessment of non-heart-beating donor kidneys: A single-centre result | 2000 |
|
Alison Bell Dr Brian Shenton
| Standardization of lymphocyte antibody binding capacity - a multi-centre study | 2000 |
|
Dr Ian Brotherick Dr Brian Shenton Dr Brian Angus Jagnohan Varma Professor Frederick Campbell et al. | Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancer | 1999 |
|
Dr Daya Karat Dr Ian Brotherick Dr Brian Shenton Dr Debbie Scott Professor Michael Griffin et al. | Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study | 1999 |
|
Dr Ian Brotherick Dr Brian Shenton Ronald Wilson Professor Frederick Campbell
| Growth dysregulation and p53 accumulation in human primary colorectal cancer | 1999 |
|
Dr David Cook Dr Ian Brotherick Dr Brian Shenton Emeritus Professor Colin Self
| Lectin ELISA for the c-erb-B2 tumor marker protein p185 in patients with breast cancer and controls | 1999 |
|
Dr Pudhupalayam Bhaskar Dr Brian Shenton Jagnohan Varma Dr Stephen Ball
| The effect of growth hormone on intestinal cell proliferation, cell cycle regulation, and growth factor receptor expression in vitro | 1999 |
|
Dr Brian Shenton Dr Sukhamay Ghosh
| Treatment of the columnar lined oesophagus with argon plasma coagulation - Effect on pathology, p53 staining and flow cytometry | 1999 |
|
Dr Ian Brotherick Professor Craig Robson Dr Jonathan Shenfine Michael White William Cunliffe et al. | Cytokeratin expression in breast cancer: Phenotypic changes associated with disease progression | 1998 |
|
Dr Brian Shenton Alison Bell Gary Cavanagh Dr Andrew Robson
| Importance of methodology in the flow cytometric crossmatch: A multicentre study | 1996 |
|
Dr Ian Brotherick Dr Brian Shenton Professor Thomas Lennard
| Are fine needle breast aspirates representative of the underlying solid tumor: a comparison on receptor levels, ploidy and the influence of cytokeratin gates | 1995 |
|
Dr Ian Brotherick Dr Brian Shenton Dr William Cowan Dr Brian Angus Professor Thomas Lennard et al. | P53 expression measured by flow cytometry: a comparison of 3 monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancer | 1995 |
|
Dr Ian Brotherick Dr Brian Shenton Dr Brian Angus Ian Waite Professor Thomas Lennard et al. | A flow cytometric study of c-erbB-3 expression in breast cancer | 1995 |
|
Dr Ian Brotherick Dr Brian Shenton Dr William Cowan Dr Brian Angus Professor Thomas Lennard et al. | Relationship between flow cytometric and immunohistochemically detected C-ERBB-2 expression, grade and DNA ploidy in breast cancer | 1995 |
|
Dr Ian Brotherick Professor Thomas Lennard Susan Cook Dr Brian Shenton
| Use of the biotinylated antibody dako-ER 1D5 to measure estrogen receptor on cytokeratin positive cells obtained from primary breast cancer cells | 1995 |
|
Dr Ian Brotherick Professor Thomas Lennard Susan Cook Dr Brian Shenton
| Flow cytometric method for the measurement of epidermal growth-factor receptor and comparison with the radio-ligand binding assay | 1994 |
|
Dr Brian Shenton Professor Thomas Lennard George Proud Robert Taylor
| Administration of ATG according to the absolute lymphocyte-T count during therapy for steroid-resistant rejection | 1993 |
|
Dr Ian Brotherick Dr Brian Shenton Emeritus Professor John Kirby Dr Jeremy Palmer Emeritus Professor Steve Yeaman et al. | Production of immunosuppressive factors by a cultured tumor cell line and their effect on lymphocyte proliferation and cells cycle response | 1993 |
|
David Talbot Gary Cavanagh Dr Brian Shenton Professor Thomas Lennard George Proud et al. | Improved graft outcome and reduced complications due to flow cytometric cross matching and DR matching in renal transplantation | 1992 |
|
Dr Brian Shenton Dr Ian Brotherick Robert Taylor Professor Thomas Lennard
| Alterations in circulating lymphocyte number and function after circulation through colorectal carcinomas | 1991 |
|
Emeritus Professor John Kirby Dr Brian Shenton Professor Thomas Lennard
| Human endothelial cells: effect of TNF-alpha on peripheral blood mononuclear cell adhesion | 1991 |
|
Dr Ian Corbett Dr Brian Shenton Professor Thomas Lennard
| Node negative breast cancer: the prognostic value of DNA ploidy for long-term survival | 1991 |
|
Emeritus Professor John Kirby Dr Brian Shenton Professor Thomas Lennard George Proud Robert Taylor et al. | Renal allograft rejection: functional impairment of kidney epithelial cell monolayers mediated by lymphokine activated killer cells and by antibody | 1991 |
|
Emeritus Professor John Kirby Dr Brian Shenton George Proud Professor Thomas Lennard Robert Taylor et al. | Renal epithelium: reversal of cytotoxic damage by addition of anti-thymocyte globulin | 1991 |
|
Dr Brian Shenton Dr Pauline Chambers Professor Thomas Lennard
| Assay of epidermal growth factor receptor by flow cytometry: a comparison with radio ligand binding assay | 1990 |
|
Professor Thomas Lennard George Proud Dr Brian Shenton Michael White Robert Taylor et al. | Blood transfusion and surgery: the effect on growth and a syngeic sarcoma | 1990 |
|
Emeritus Professor John Kirby Dr Brian Shenton David Talbot Professor Thomas Lennard George Proud et al. | Renal allograft rejection: possible involvement of antibody dependent cell mediated cytotoxicity | 1990 |
|
David Talbot Dr Brian Shenton Professor Thomas Lennard George Proud Robert Taylor et al. | The prospective value of the properative flow cytometric cross match assay in renal transplantation | 1990 |
|
Dr Brian Shenton Robert Taylor Professor Thomas Lennard
| A flow cytometric technique for simultaneous analysis of human mononuclear cell surface antigens and DNA | 1989 |
|
Dr Brian Shenton Robert Taylor Professor Thomas Lennard
| The effect of colorectal carcinoma on lymphocytes-T circulating through the tumor | 1989 |
|
Professor Thomas Lennard Dr Brian Shenton Robert Taylor
| A phase-I study of immunostimulation and toxocity in patients with colorectal-carcinoma using the immunomodular 3,6-BIS(2-piperidinoethoxy) acridine trihydrochloride (CL-246738) | 1989 |
|
Dr Brian Shenton Professor Thomas Lennard Robert Taylor
| Circulating lymphocyte subpopulations and NK cell-activity in the rat model of azoxymethane induced colon neoplasia | 1989 |
|
Dr Brian Shenton Professor Thomas Lennard David Talbot Michael White George Proud et al. | The predictive value of immunological monitoring in the early postoperative period in renal transplant patients | 1988 |
|
David Talbot Dr Brian Shenton Ronald Wilson Professor Thomas Lennard George Proud et al. | Value of the flow cytometric cross match in renal transplantation | 1987 |
|
Robert Taylor Professor Thomas Lennard Dr Brian Shenton George Proud
| THE BLOOD-TRANSFUSION EFFECT AND COLORECTAL-CANCER RECURRENCE | 1987 |
|
Ronald Wilson Dr Brian Shenton Robert Taylor George Proud
| Aspirate cellularity as a rapid indicator of renal allograft rejection | 1986 |
|
Professor Thomas Lennard Robert Taylor George Proud Dr Brian Shenton
| Effect of perioperative blood transfusion on recurrence of colorectal cancer | 1986 |
|
Professor Thomas Lennard Dr Brian Shenton Michael White George Proud Robert Taylor et al. | Influence of blood transfusions on circulating lymphocyte subpopulations | 1986 |
|
Ronald Wilson Dr Brian Shenton Professor Thomas Lennard Robert Taylor George Proud et al. | T helper suppressor ratio distinguishes cyclosporine nephrotoxicity from rejection | 1986 |
|
Professor Thomas Lennard Dr Brian Shenton George Proud Robert Taylor
| The effect of perioperative blood transfusion on colorectal cancer recurrence | 1986 |
|
Dr Brian Shenton Professor Thomas Lennard George Proud Robert Taylor
| CAPD and renal transplantation | 1985 |
|
Professor Thomas Lennard Dr Brian Shenton Emeritus Professor Reg Jordan George Proud Robert Taylor et al. | Circulating leukocyte subpopulations and their function in benign and malignant disease | 1985 |
|
Professor Thomas Lennard Dr Brian Shenton Emeritus Professor Reg Jordan George Proud Robert Taylor et al. | Circulating leukocyte subpopulations and their functions in benign and malignant disease | 1985 |
|
Professor Thomas Lennard Dr Brian Shenton George Proud Robert Taylor
| Flow cytometric analysis of lymphocyte subpopulations during tumor growth in rats: a fall in helper lymphocytes-T in the 1st 7 days after inoculation | 1985 |
|
Professor Anne Dickinson Dr Brian Shenton Professor Stephen Proctor
| Inhibition of natural killing and antibody-dependent cell-mediated cytotoxicity by the plasma protease inhibitor α2-macroglobulin (α2M) and α2M protease complexes | 1985 |
|
Professor Thomas Lennard Dr Brian Shenton George Proud Robert Taylor
| Lymphocyte-T subpopulations in the blood, primary tumor and normal colonic mucosa of patients with colorectal carcinoma | 1985 |
|
Professor Thomas Lennard Dr Brian Shenton George Proud Robert Taylor
| Natural immunity during tumor growth flow cytometric enumeration of lymphocyte subpopulations during growth of an MC7 sarcoma in rats | 1985 |
|
Professor Thomas Lennard Dr Brian Shenton George Proud Robert Taylor
| The influence of surgical operations on components of the human immune system | 1985 |
|
George Proud Dr Brian Shenton Professor Thomas Lennard Robert Taylor
| Are DRW6-positive patients high responders | 1984 |
|
Professor Thomas Lennard Robert Taylor Dr Brian Shenton George Proud
| Insitu subpopulations of lymphocytes in human colorectal carcinomas | 1984 |
|
Professor Thomas Lennard Robert Taylor Dr Brian Shenton George Proud
| Reversed OKT4/OKT8 ratio insitu in human colorectal carcinomas: quantitative study using cryostat immunohistochemistry | 1984 |
|
Professor Thomas Lennard Robert Taylor Dr Brian Shenton George Proud
| Reversed OKT4/OKT8 ratio insitu in human colorectal carcinomas: a qualitative study using cryostat immunohistochemistry | 1983 |
|